在AMI中,VA-ECMO的断奶策略采用了通过血管活性无otropic评分调整的脉冲压,而AMI因心脏性冲击而复杂
Bo Ram Lee1, Ki Hong Choi2, Eun Jin Kim2
1Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
ESC heart failure
|May 9, 2024
概括
在静脉外体膜氧化 (VA-ECMO) 启动12小时后,通过血管活性无otropic评分 (VIS) 调整的脉冲压预测了心肌梗塞与心脏性休克 (AMI-CS) 的急性心肌梗塞患者的断奶成功. 低调节的脉压表明死亡风险更高.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 心血管外科心血管外科
背景情况:
- 带有心脏性休克的急性心肌梗塞 (AMI-CS) 是一种需要先进的循环支持的危急状况.
- 静脉脉外体膜氧化 (VA-ECMO) 是严重的AMI-CS.的救生疗法.
- 预测VA-ECMO断奶成功和患者结果对于临床管理至关重要.
研究的目的:
- 为了评估连续脉冲压 (PP) 和PP的预测值,调整为VA-ECMO在AMI-CS患者的断奶成功的血管活性内托普分数 (VIS).
- 评估这些参数与临床结果 (包括死亡率) 的关联.
主要方法:
- 对213名接受VA-ECMO的AMI-CS患者进行了回顾性分析.
- 在VA-ECMO插入后0,12,24和48小时进行PP和VIS的连续测量.
- 通过VIS (PP/√VIS) 调整的PP的计算,并评估其对断奶成功的辨别能力.
主要成果:
- 在70.9%的患者中,VA-ECMO奶成功实现.
- 插入后12小时的PP/√VIS在成功断奶的患者中显着更高 (10.1比2.9,P<0.001).
- 与单独PP相比,12小时的PP/√VIS显示出优异的分辨功能,与单独PP相比,断奶成功 (AUC为0.80对0.67).
- 低12小时PP/√VIS (≤7) 与显著更高的住院和6个月死亡率有关.
结论:
- 在VA-ECMO启动12小时后,通过VIS (PP/√VIS) 调整的脉冲压是AMI-CS患者断奶成功的可靠预测指标.
- 低12小时PP/√VIS值是增加死亡风险的重要指标.
- 这种调整后的PP指标为优化VA-ECMO患者的临床管理和预后提供了宝贵的工具.
关键词:
剧烈的心肌梗塞急性心肌梗塞心脏发生的冲击是心脏的冲击.身体外膜氧化器的氧化脉冲压力是指脉冲的压力.血管活性异型评分 (Vasoactive Inotropic Score) 是指血管活性异型评分.更多相关视频
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
285
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.6K
相关概念视频
Heart Failure Drugs: Inotropic Agents
573
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
573
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Decreased pulse rate
540
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
540
Blood Pressure Imbalances and Circulatory Shock
772
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
772
